Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2000, p. 2569-2571, Vol. 44, No. 9
Department of Visceral and Transplantation
Surgery, University of Bern, Bern, Switzerland,1
and Pfizer Mack Research Laboratory, Illertissen,
Germany2
Received 18 January 2000/Returned for modification 17 March
2000/Accepted 24 May 2000
Because of antibiotic prophylaxis for necrotizing pancreatitis, the
frequency of fungal superinfection in patients with pancreatic necrosis
is increasing. In this study we analyzed the penetration of fluconazole
into the human pancreas and in experimental acute pancreatitis. In
human pancreatic tissues, the mean fluconazole concentration was
8.19 ± 3.38 µg/g (96% of the corresponding concentration in
serum). In experimental edematous and necrotizing pancreatitis, 88 and
91% of the serum fluconazole concentration was found in the pancreas.
These data show that fluconazole penetration into the pancreas is
sufficient to prevent and/or treat fungal contamination in patients
with pancreatic necrosis.
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Fluconazole Penetration into the Pancreas
*
Corresponding author. Mailing address: Department of
Visceral and Transplantation Surgery, University of Bern, Inselspital, CH-3010 Bern, Switzerland. Phone: 41 31 632 9578. Fax: 41 31 632 9732. E-mail: helmut.friess{at}insel.ch.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»